Analyse the application of personalised lung cancer care by critically evaluating the latest NCCN guidelines, tumour molecular profiling, and MDT approaches to develop tailored treatment plans that optimise patient outcomes.

Evaluate the efficacy of advanced therapies, including stereotactic body radiotherapy (SBRT), minimally invasive surgical approaches, oncological targeted therapies etc. through the assessment of real case studies to determine their impact on early-stage and complex lung cancer cases.

Synthesise regional and global best practices in lung cancer care by fostering collaboration and networking, enabling attendees to apply these insights to enhance the standard of care and patient access to innovative treatments across the GCC.